Noninvasive imaging of protein–protein interactions in living animals
暂无分享,去创建一个
Wei Li | Gary D Luker | David Piwnica-Worms | Vijay Sharma | Wei Li | H. Piwnica-Worms | C. Ryan | D. Piwnica-Worms | G. Luker | C. Pica | J. Dahlheimer | Helen Piwnica-Worms | Christina M Pica | Julie L Dahlheimer | Joseph Ochesky | Christine E Ryan | V. Sharma | Joseph Ochesky | Julie L. Dahlheimer
[1] R. Esnouf,et al. Characterization of multiple nuclear localization signals in herpes simplex virus type 1 thymidine kinase. , 1999, Biochemical and biophysical research communications.
[2] A. Jacobs,et al. Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression. , 1999, Neoplasia.
[3] B. Schaffhausen. Transforming genes and gene products of polyoma and SV40. , 1982, CRC critical reviews in biochemistry.
[4] R. DePinho,et al. Use of the human EF-1alpha promoter for expression can significantly increase success in establishing stable cell lines with consistent expression: a study using the tetracycline-inducible system in human cancer cells. , 1999, Nucleic acids research.
[5] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[6] M. Welch,et al. Novel gallium(III) complexes transported by MDR1 P-glycoprotein: potential PET imaging agents for probing P-glycoprotein-mediated transport activity in vivo. , 2000, Chemistry & biology.
[7] S. Cherry,et al. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] P. Friedman,et al. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. , 1992, Genes & development.
[9] K. Kinzler,et al. Identification and classification of p53-regulated genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[10] P. Uetz,et al. Towards an understanding of complex protein networks. , 2001, Trends in cell biology.
[11] P. Conti,et al. Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG): a new potential imaging agent for viral infection and gene therapy using PET. , 1998, Nuclear medicine and biology.
[12] M. T. Hasan,et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] D. Piwnica-Worms,et al. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation. , 1995, Biochemistry.
[14] James F. Young,et al. MicroPET: a high resolution PET scanner for imaging small animals , 1996, IEEE Nuclear Science Symposium Conference Record.
[15] A. Varshavsky,et al. Split ubiquitin as a sensor of protein interactions in vivo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Mullins,et al. Conditional transgenic technologies. , 2001, The Journal of endocrinology.
[17] R. Blasberg,et al. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] B. Snel,et al. Comparative assessment of large-scale data sets of protein–protein interactions , 2002, Nature.
[19] S. Michnick,et al. Clonal selection and in vivo quantitation of protein interactions with protein-fragment complementation assays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[20] S. Fields,et al. A novel genetic system to detect proteinprotein interactions , 1989, Nature.
[21] H. Blau,et al. Monitoring protein-protein interactions in intact eukaryotic cells by beta-galactosidase complementation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[22] K. Harter,et al. The NAF domain defines a novel protein–protein interaction module conserved in Ca2+‐regulated kinases , 2001, The EMBO journal.
[23] Y. Erdi,et al. Standardized uptake value in pediatric patients: an investigation to determine the optimum measurement parameter , 2001, European Journal of Nuclear Medicine and Molecular Imaging.
[24] A. Aronheim,et al. The Ras recruitment system, a novel approach to the study of protein–protein interactions , 1998, Current Biology.
[25] G. Stark,et al. How cells respond to interferons. , 1998, Annual review of biochemistry.
[26] E. Golemis,et al. Redefinition of the yeast two-hybrid system in dialogue with changing priorities in biological research. , 2001, BioTechniques.
[27] M. Gossen,et al. Co-regulation of two gene activities by tetracycline via a bidirectional promoter. , 1995, Nucleic acids research.
[28] H. Shimada,et al. Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[29] M. Black,et al. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[30] H. Blau,et al. Interaction blues: protein interactions monitored in live mammalian cells by beta-galactosidase complementation. , 2000, Trends in cell biology.
[31] S. Cherry,et al. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[32] E. Golemis,et al. Using the yeast interaction trap and other two-hybrid-based approaches to study protein-protein interactions. , 2001, Methods.
[33] J. Barrio,et al. Assays for noninvasive imaging of reporter gene expression. , 1999, Nuclear medicine and biology.
[34] S. Elledge,et al. Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions , 1997, Molecular and cellular biology.
[35] Gary D Luker,et al. Visualizing protein-protein interactions in living animals. , 2003, Methods.
[36] R G Blasberg,et al. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. , 1996, Cancer research.
[37] I. Wilson,et al. Erythropoietin receptor activation by a ligand-induced conformation change. , 1999, Science.
[38] S S Gambhir,et al. Noninvasive quantitative imaging of protein–protein interactions in living subjects , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[39] D. Piwnica-Worms,et al. Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. , 2000, Bioconjugate chemistry.
[40] A. Galarneau,et al. β-Lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein–protein interactions , 2002, Nature Biotechnology.
[41] R. Blasberg,et al. Imaging the expression of transfected genes in vivo. , 1995, Cancer research.
[42] J. Bading,et al. Preclinical evaluation of the penciclovir analog 9-(4-[(18)F]fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[43] David M. Livingston,et al. A Complex with Chromatin Modifiers That Occupies E2F- and Myc-Responsive Genes in G0 Cells , 2002, Science.
[44] P. Conti,et al. 9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): a potential imaging agent of viral infection and gene therapy using PET. , 1996, Nuclear medicine and biology.
[45] J. Leatherwood,et al. A potent GAL4 derivative activates transcription at a distance in vitro. , 1990, Science.
[46] M. Lewandoski. Conditional control of gene expression in the mouse , 2001, Nature Reviews Genetics.
[47] Blasberg Rg,et al. Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy. , 1999 .
[48] R. L. Jarvest,et al. Synthesis and antiviral activity of 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]purines. , 1987, Journal of medicinal chemistry.
[49] Jan Tavernier,et al. Design and application of a cytokine-receptor-based interaction trap , 2001, Nature Cell Biology.
[50] Hailan Zhang,et al. Heterodimerization of Msx and Dlx homeoproteins results in functional antagonism , 1997, Molecular and cellular biology.
[51] I. Stagljar,et al. A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[52] M. Black,et al. Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[53] J. Milbrandt,et al. In Vitro and In Vivo Characterization of a Dual-Function Green Fluorescent Protein–HSV1-Thymidine Kinase Reporter Gene Driven by the Human Elongation Factor 1α Promoter , 2002, Molecular imaging.
[54] C. Heldin,et al. Signal Transduction: Multiple Pathways, Multiple Options for Therapy , 2001, Stem cells.
[55] S. Larson,et al. Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer , 2001, Nature Medicine.